BlueWillow Biologics IPO

BlueWillow Biologics (also known as NanoBio) are the developer of intranasal vaccines that help protect global populations from food allergies, sexually transmitted diseases and respiratory infections. This company was founded in 2000 by James Baker and is headquartered in Ann Arbor, MI. BlueWillow's antiseptic and anti-infective products as well as NanoVax are using a patented nanotechnology platform to administrate nano-droplets to the skin and nose.

Register for Details

For more details on financing and valuation for BlueWillow Biologics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about BlueWillow Biologics

Forge green plus iconForge green minus icon

What is BlueWillow Biologics's IPO price?

The IPO price for BlueWillow Biologics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in BlueWillow Biologics?

BlueWillow Biologics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell BlueWillow Biologics shares pre-IPO?

If you own BlueWillow Biologics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is BlueWillow Biologics a publicly traded company?

BlueWillow Biologics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is BlueWillow Biologics's funding to date?

BlueWillow Biologics has raised $37.19MM to date.
Forge green plus iconForge green minus icon

When was BlueWillow Biologics founded?

BlueWillow Biologics was founded in 2000.

Who are BlueWillow Biologics's major investors?

Bill & Melinda Gates Foundation
National Institute of Allergy and Infectious Diseases
North Coast Technology Investors
Small Business Innovation Research

BlueWillow Biologics Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
9/19/2022 Series C $5.9MM raised $XXX.XX $XXX.XX
3/31/2020 Series B $9.95MM raised $XXX.XX $XXX.XX
5/7/2018 Series A $9.23MM raised $XXX.XX $XXX.XX
11/28/2012 Series A-1 $12.11MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Apr 22, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.